Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 8-9, Août–Septembre 2015
Page(s) 748 - 755
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153108013
Publié en ligne 4 septembre 2015
  1. Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol 2012 ; 33 : 579–589. [CrossRef]
  2. Battistini L, Piccio L, Rossi B, et al. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 2003 ; 101 : 4775–4782. [CrossRef] [PubMed]
  3. Na SY, Hermann A, Sanchez-Ruiz M, et al. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity 2012 ; 37 : 134–146. [CrossRef] [PubMed]
  4. Kooij G, Kroon J, Paul D, et al. P-glycoprotein regulates trafficking of CD8+ T cells to the brain parenchyma. Acta Neuropathol 2014 ; 127 : 699–711. [CrossRef] [PubMed]
  5. Compston A, Coles A. Multiple sclerosis. Lancet 2008 ; 372 : 1502–1517. [CrossRef] [PubMed]
  6. Crawford MP, Yan SX, Ortega SB, et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004 ; 103 : 4222–4231. [CrossRef] [PubMed]
  7. Jilek S, Schluep M, Rossetti AO, et al. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. Clin Immunol 2007 ; 123 : 105–113. [CrossRef] [PubMed]
  8. Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000 ; 192 : 393–404. [CrossRef] [PubMed]
  9. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002 ; 25 : 313–319. [CrossRef] [PubMed]
  10. Serafini B, Rosicarelli B, Magliozzi R, et al. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 2006 ; 65 : 124–141. [PubMed]
  11. Chevalier G, Suberbielle E, Monnet C, et al. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog 2011 ; 7 : e1002393. [CrossRef] [PubMed]
  12. Pignolet BS, Gebauer CM, Liblau RS. Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: a beneficial antitumor immune response going awry. Oncoimmunology 2013 ; 2 : e27384. [CrossRef] [PubMed]
  13. De Beukelaar JW, Verjans GM, van Norden Y, et al. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies. Cancer Immunol Immunother 2007 ; 56 : 1501–1506. [CrossRef] [PubMed]
  14. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012 ; 135 : 1622–1638. [CrossRef] [PubMed]
  15. Waki K, Yamada S, Ozawa Y, et al. A case of lymphocytic infundibuloneurohypophysitis: histophathological studies. Pituitary 1999 ; 1 : 285–290. [CrossRef] [PubMed]
  16. Scheikl T, Pignolet B, Dalard C, et al. Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus. J Immunol 2012 ; 188 : 4731–4735. [CrossRef]
  17. Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Ann Neurol 2002 ; 51 : 311–318. [CrossRef] [PubMed]
  18. Brien JD, Uhrlaub JL, Nikolich-Zugich J. Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection. Eur J Immunol 2007 ; 37 : 1855–1863. [CrossRef] [PubMed]
  19. Pinschewer DD, Schedensack M, Bergthaler A, et al. T cells can mediate viral clearance from ependyma but not from brain parenchyma in a major histocompatibility class I- and perforin-independent manner. Brain 2010 ; 133 : 1054–1066. [CrossRef] [PubMed]
  20. Brew BJ, Davies NW, Cinque P, et al. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 2010 ; 6 : 667–679. [CrossRef] [PubMed]
  21. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 2012 ; 366 : 1870–1880. [CrossRef] [PubMed]
  22. Du Pasquier RA, Kuroda MJ, Zheng Y, et al. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004 ; 127 : 1970–1978. [CrossRef] [PubMed]
  23. Martin-Blondel G, Delobel P, Blancher A, et al. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011 ; 134 : 928–946. [CrossRef] [PubMed]
  24. Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010 ; 10 : 251–261. [CrossRef] [PubMed]
  25. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011 ; 76 : 1697–1704. [CrossRef] [PubMed]
  26. Martin-Blondel G, Bauer J, Cuvinciuc V, et al. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection. Neurology 2013 ; 81 : 964–970. [CrossRef] [PubMed]
  27. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009 ; 73 : 1551–1558. [CrossRef] [PubMed]
  28. Antoniol C, Jilek S, Schluep M, et al. Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management? Neurology 2012 ; 79 : 2258–2264. [CrossRef] [PubMed]
  29. Martin-Blondel G, Alvarez M, Delobel P, et al. Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 2011 ; 82 : 691–693. [CrossRef] [PubMed]
  30. Gray F, Bazille C, Adle-Biassette H, et al. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 2005 ; 11 (suppl 3) : 16–22. [CrossRef]
  31. Polman CH, O’Connor PW, Havrdova E, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 ; 354 : 899–910. [CrossRef] [PubMed]
  32. Kappos L, Radue EW, O’Connor P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010 ; 362 : 387–401. [CrossRef] [PubMed]
  33. Giacomini PS, Rozenberg A, Metz I, et al. Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome. N Engl J Med 2014 ; 370 : 486–488. [CrossRef] [PubMed]
  34. Martin-Blondel G, Cuzin L, Delobel P, et al. Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? Aids 2009 ; 23 : 2545–2546. [CrossRef] [PubMed]
  35. Molon B, Gri G, Bettella M, et al. T cell costimulation by chemokine receptors. Nat Immunol 2005 ; 6 : 465–471. [CrossRef] [PubMed]
  36. Martin-Blondel G, Bauer J, Uro-Coste E, et al. Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8 T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome. Acta Neuropathol 2015 ; 129 : 463–465. [CrossRef] [PubMed]
  37. Chakrabarti LA, Lortholary O. L’IRIS : une réaction inflammatoire paradoxale chez les patients traités simultanément pour une tuberculose et une infection par le VIH. Med Sci (Paris) 2015 ; 31 : 53–59. [CrossRef] [EDP Sciences] [PubMed]
  38. Breton G. Syndrome inflammatoire de reconstitution immune. Med Sci (Paris) 2010 ; 26 : 281–289. [CrossRef] [EDP Sciences] [PubMed]
  39. Louapre C, Maillart E, Papeix C, Lubetzki C. Nouveautés thérapeutiques et stratégies émergentes dans la sclérose en plaques. Med Sci (Paris) 2013 ; 29 : 1105–1110. [CrossRef] [EDP Sciences] [PubMed]
  40. Lanteri MC, Diamond MS, Norris PJ, Busch MP. Infection par le virus West Nile chez l’homme. II. Aspects physiopathologiques et réponses immunitaires. Med Sci (Paris) 2011 ; 27 : 382–386. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.